Exam 1: NUR210/ NUR 210 (Latest 2025/
2026 Update) Transition to Practice-
Capstone | Review with Questions and
Verified Answers| 100% Correct| Grade A –
Fortis
Nur 210 Exam 1
Pharmacology:
The study of chemicals that alter the function of a living organism
- Drugs:
Any chemical that is capable of interacting with a living organism to produce a biological effect.
- Herbs and supplements:
When we get our patient's health history it is important to ask them if they're currently taking any
herbs or supplements and how much because it can interact with the different medications that
we might put them on.
- Ace Inhibitors (drug class) was originally from
the venom of Brazillian Pit Viper snakes because it helped with hypertension
- Botulinum toxin (better known as botox) was a
toxin potent from spoiled sausages and was used to treat facial wrinkles.
- Warfarin (Cumin) is a
,blood thinner medication and it originally came from rat poison.
- Curare:
A muscle relaxant that is used in anesthesia that comes from poisonous dart frogs in South
America.
- Federal Pure Food and Drug Act of 1906:
This law set standards for drug quality and purity in addition to strength. It specifically focused
on product labeling and required that any variations from the standards be placed on the label.
- The Food, Drug and Cosmetic Act of 1938:
was the first legislation to address drug safety. They passed this act because more than 100
people died following the use of a new medication because it had an automotive freeze in the
medication. This Act set standards for how compounding pharmacies could make medications.
The drugs had to be pure with no additives and undergo testing to ensure that there was no
toxicity.
- Kefauver - Harris Amendment of 1962:
This act states that drugs must be proven to be effective and work properly.
- Controlled Substance Act of 1970:
This legislation set rules for the manufacturer and distribution of drugs considered to have
potential for abuse. One provision of the law defines five categories of controlled substances,
referred to as Schedules I, II, III, IV, and V.
- Orphan Drug Act of 1983:
, Pharmaceutical companies are given a tax break if they make medications for rare diseases such
as Hungtington's disease, HIV, AIDS, ALS, and Tourette syndrome
- Experimental Drugs for the Desperately ill of 1992:
FDA regulations were changed to permit accelerated approval of drugs for acquired
immunodeficiency syndrome (AIDS) and cancer. Under these guidelines, a drug could be
approved for marketing before completion of phase III trials, provided that rigorous follow up
studies were performed. The rationale for this change was that (1) medications are needed, even
if their benefits may be marginal, and (2) the unknown risk associated with early approval are
balanced by the need for more effective drugs.
- The Food and Drug Administration Modernization Act (FDAMA) of 1997:
Manufacturers who plan to stop making a drug must inform patients at least six months in
advance, thereby giving them time to find another source. This is also when they started doing
research on kids and pregnant woman.
- Best Pharmaceutical for Children Act (BPCA) of 2002 and Pediatric Research Equity Act
(PREA) of 2003
were designed to promote much needed research on drug efficacy and safety in children. The
BPCA offers a 6 month patent extension to manufacturers who evaluate a drug already on the
market for its safety, efficacy, and dosage in children. The PREA gives the FDA the power, for
the first time, to require drug companies to conduct pediatric clinical trials on new medications
that might be used by children.
- FDA Amendments Act (FDAAA) of 2007:
2026 Update) Transition to Practice-
Capstone | Review with Questions and
Verified Answers| 100% Correct| Grade A –
Fortis
Nur 210 Exam 1
Pharmacology:
The study of chemicals that alter the function of a living organism
- Drugs:
Any chemical that is capable of interacting with a living organism to produce a biological effect.
- Herbs and supplements:
When we get our patient's health history it is important to ask them if they're currently taking any
herbs or supplements and how much because it can interact with the different medications that
we might put them on.
- Ace Inhibitors (drug class) was originally from
the venom of Brazillian Pit Viper snakes because it helped with hypertension
- Botulinum toxin (better known as botox) was a
toxin potent from spoiled sausages and was used to treat facial wrinkles.
- Warfarin (Cumin) is a
,blood thinner medication and it originally came from rat poison.
- Curare:
A muscle relaxant that is used in anesthesia that comes from poisonous dart frogs in South
America.
- Federal Pure Food and Drug Act of 1906:
This law set standards for drug quality and purity in addition to strength. It specifically focused
on product labeling and required that any variations from the standards be placed on the label.
- The Food, Drug and Cosmetic Act of 1938:
was the first legislation to address drug safety. They passed this act because more than 100
people died following the use of a new medication because it had an automotive freeze in the
medication. This Act set standards for how compounding pharmacies could make medications.
The drugs had to be pure with no additives and undergo testing to ensure that there was no
toxicity.
- Kefauver - Harris Amendment of 1962:
This act states that drugs must be proven to be effective and work properly.
- Controlled Substance Act of 1970:
This legislation set rules for the manufacturer and distribution of drugs considered to have
potential for abuse. One provision of the law defines five categories of controlled substances,
referred to as Schedules I, II, III, IV, and V.
- Orphan Drug Act of 1983:
, Pharmaceutical companies are given a tax break if they make medications for rare diseases such
as Hungtington's disease, HIV, AIDS, ALS, and Tourette syndrome
- Experimental Drugs for the Desperately ill of 1992:
FDA regulations were changed to permit accelerated approval of drugs for acquired
immunodeficiency syndrome (AIDS) and cancer. Under these guidelines, a drug could be
approved for marketing before completion of phase III trials, provided that rigorous follow up
studies were performed. The rationale for this change was that (1) medications are needed, even
if their benefits may be marginal, and (2) the unknown risk associated with early approval are
balanced by the need for more effective drugs.
- The Food and Drug Administration Modernization Act (FDAMA) of 1997:
Manufacturers who plan to stop making a drug must inform patients at least six months in
advance, thereby giving them time to find another source. This is also when they started doing
research on kids and pregnant woman.
- Best Pharmaceutical for Children Act (BPCA) of 2002 and Pediatric Research Equity Act
(PREA) of 2003
were designed to promote much needed research on drug efficacy and safety in children. The
BPCA offers a 6 month patent extension to manufacturers who evaluate a drug already on the
market for its safety, efficacy, and dosage in children. The PREA gives the FDA the power, for
the first time, to require drug companies to conduct pediatric clinical trials on new medications
that might be used by children.
- FDA Amendments Act (FDAAA) of 2007:
